Loading...
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
Elevated expression of the chemokine receptor CCR4 in tumors is associated with poor prognosis in several cancers. Here, we have determined that CCR4 was highly expressed in human renal cell carcinoma (RCC) biopsies and observed abnormal levels of CCR4 ligands in RCC patient plasma. An antagonistic...
Saved in:
Published in: | J Clin Invest |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
American Society for Clinical Investigation
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330727/ https://ncbi.nlm.nih.gov/pubmed/28134623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI82976 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|